Successful Treatment of South American Rattlesnake (Crotalus durissus terrificus) Envenomation with Crotalidae Polyvalent Immune Fab (CroFab™)

Journal of Medical Toxicology

Volumn 7, Issue 1, 2011, Pages 44-46

  Lynch, Michael J ^a   Ritter, Seth C ^b   Cannon, Robert D ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; FIBRINOGEN; SNAKE VENOM ANTISERUM;

ADULT; ARTICLE; ATAXIA; CASE REPORT; DIPLOPIA; DISEASE SEVERITY; DOSE RESPONSE; ENVENOMATION; HAND PARESTHESIA; HUMAN; HYPOFIBRINOGENEMIA; INDEX FINGER; LOADING DRUG DOSE; MAINTENANCE THERAPY; MALE; ORAL PARESTHESIA; PAIN; RECURRENT DISEASE; SNAKEBITE; SOUTH AMERICA; SWELLING; TREATMENT OUTCOME;

ADULT; ANIMALS; ANTIVENINS; CROTALUS; HUMANS; IMMUNOGLOBULIN FRAGMENTS; MALE; SNAKE BITES; SPECIES SPECIFICITY; TREATMENT OUTCOME; UNITED STATES;

EID: 79952630033     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/s13181-010-0100-z     Document Type: Article

References (7)

1. Sano-Martins IS, Tomy SC, Campolina D, Dias MB, de Castro SC, de Sousa-e-Silva MC, Amaral CF et al (2001) Coagulopathy following lethal and non-lethal envenoming of humans by the South American rattlesnake (Crotalus durissus) in Brazil. QJM 94(10): 551-559.
2. Dart RC, Seifert SA, Boyer LV, Clark RF, Hall E, McKinney P, McNally J et al (2001) A randomized multicenter trial of cpolyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med 161(16): 2030-2036.
3. Jurkovich GJ, Luterman A, McCullar K, Ramenofsky ML, Curreri PW (1988) Complications of Crotalidae antivenin therapy. J Trauma 28(7): 1032-1037.
4. Ruha AM, Curry SC, Beuhler M, Katz K, Brooks DE, Graeme KA, Wallace K et al (2002) Initial postmarketing experience with Crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation. Ann Emerg Med 39(6): 609-615.
5. Boyer LV, Seifert SA, Cain JS (2001) Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 2. Guidelines for clinical management with crotaline Fab antivenom. Ann Emerg Med 37(2): 196-201.
6. Gopalakrishnakone P, Hawgood BJ, Holbrooke SE, Marsh NA, Santana De Sa S, Tu AT (1980) Sites of action of Mojave toxin isolated from the venom of the Mojave rattlesnake. Br J Pharmacol 69(3): 421-431.
7. Richardson WH 3rd, Tanen DA, Tong TC, Betten DP, Carstairs SD, Williams SR, Cantrell FL et al (2005) Crotalidae polyvalent immune Fab (ovine) antivenom is effective in the neutralization of South American Viperidae venoms in a murine model. Ann Emerg Med 45(6): 595-602.